This raises the possibility that CD109 protein release is enhanced in psoriatic keratinocytes and suggest that aberrant CD109 release from the cell surface in human keratinocytes may induce molecular changes that are observed in psoriasis (28). This evidence concerns the gene CD109 and psoriasis.